Anita Giobbie‐Hurder

Dana-Farber Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Papers

Driven by 32 papers — median percentile 0. Top paper: “Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial”.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00658-6

N/A

4.8DataRank · unranked

234 citations

Anita Giobbie‐Hurder, Srinika Ranasinghe, Katrina Kao, Ana Lako, Junko Tsuji +32 more

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

Nature Medicine(2021)10.1038/s41591-020-01206-4

N/A

4.5DataRank · unranked

525 citations

Donna Leet, Rosa Lundbye Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne Luoma +36 more

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z

N/A

1.8DataRank · unranked

48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Nature(2018)10.1038/s41586-018-0792-9

N/A

1.1DataRank · unranked

1412 citations

Jing Sun, Itay Tirosh, Nathan D. Mathewson, Shuqiang Li, Giacomo Oliveira +51 more

Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.12.001

N/A

0.804DataRank · unranked

212 citations

Sushil Kumar, Peng Jiang, Jason W. Pyrdol, Angela E. Zou, Anže Godicelj +11 more

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci157171

N/A

0.793DataRank · unranked

29 citations

Ashley K. Gartin, Mofei Liu, Jingwei Cheng, Harita Dharaneeswaran, Derin B. Keskin +5 more

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000451

N/A

0.650DataRank · unranked

75 citations

Daniel Wang, Alexandra Coromilas, Melissa Lumish, Tianqi Chen, Anita Giobbie‐Hurder +4 more

BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2108421118

N/A

0.649DataRank · unranked

11 citations

Joshua Rivera, Miklós Dióssy, Haohui Duan, Christian Bowman-Colin, Rachel Reed +13 more

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

npj Breast Cancer(2022)10.1038/s41523-022-00500-3

N/A

0.604DataRank · unranked

55 citations

Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski +21 more

Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging

Blood Advances(2023)10.1182/bloodadvances.2023009813

N/A

0.538DataRank · unranked

35 citations

Jason L. Weirather, Sizun Jiang, Katrina Kao, Yari Sigal, Anita Giobbie‐Hurder +3 more

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Cell(2025)10.1016/j.cell.2025.06.019

N/A

0.520DataRank · unranked

31 citations

Derin B. Keskin, Chloe Ran Tu, Cleo Forman, Allison P. Vanasse, Haley E. Sax +39 more

EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0171

N/A

0.500DataRank · unranked

27 citations

Dinesh Thapa, Anita Giobbie‐Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol +7 more

Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor–induced bullous pemphigoid

Journal of the American Academy of Dermatology(2022)10.1016/j.jaad.2022.06.1186

N/A

0.434DataRank · unranked

17 citations

Jordan Talia, Erin X. Wei, Arash Mostaghimi, Yevgeniy R. Semenov, Anita Giobbie‐Hurder +3 more

Characterizing the tumor and immune landscape of melanoma patients treated with combined checkpoint blockade and MAPK targeted therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9522

N/A

0.326DataRank · unranked

3 citations

Donald P. Lawrence, David F. McDermott, Mofei Liu, Elizabeth I. Buchbinder, Irena Gushterova +14 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3609

N/A

0.293DataRank · unranked

4 citations

James M. Cleary, Justine V. Cohen, Donald P. Lawrence, Elizabeth I. Buchbinder, Anita Giobbie‐Hurder +11 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027

N/A

0.292DataRank · unranked

6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more

Circulating cytokine associations with clinical outcomes in melanoma patients treated with combination nivolumab plus ipilimumab

OncoImmunology(2024)10.1080/2162402x.2024.2432723

N/A

0.292DataRank · unranked

6 citations

Giuseppe Tarantino, Mariano Severgnini, Joanna Bagińska, Anita Giobbie‐Hurder, Jason L. Weirather +14 more

Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0702

N/A

0.241DataRank · unranked

4 citations

Jingjing Li, Yue Zheng, Sandra J. Lee, Jun Zhou, Anita Giobbie‐Hurder +4 more

Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9511

N/A

0.239DataRank · unranked

3 citations

Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more

The effects of a clinic‐based weight loss program on health‐related quality of life and weight maintenance in cancer survivors: A randomized controlled trial

Psycho-Oncology(2021)10.1002/pon.5817

N/A

0.204DataRank · unranked

2 citations

Anita Giobbie‐Hurder, Rachel L. Yung, Erica L. Mayer, Sara M. Tolaney, Ann H. Partridge +2 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336.v1

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

(2023)10.1158/2326-6066.22537789

N/A

0DataRank · unranked

0 citations

Donald P. Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada +18 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets

Journal of Clinical Investigation(2024)10.1172/jci178253

N/A

0DataRank · unranked

17 citations

G. Romar, Artür Manukyan, Wei-Che Ko, Pei‐Chen Hsieh, Gustavo A. Velasquez +16 more

Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2529

N/A

0DataRank · unranked

0 citations

Ken Chang, Andrew Beers, Kyrre E. Emblem, Jayashree Kalpathy–Cramer, Eudocia Q. Lee +15 more

NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors

JAAD International(2024)10.1016/j.jdin.2024.11.004

N/A

0DataRank · unranked

0 citations

Jordan T. Said, Elliot H. Akama‐Garren, Nicole Trepanowski, Ai‐Tram N. Bui, Anita Giobbie‐Hurder +3 more

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

Genome Medicine(2020)10.1186/s13073-020-00727-4

N/A

0DataRank · unranked

121 citations

Manisha Thakuria, Tianqi Chen, Christina Marcelus, Jingwei Cheng, Jason Nomburg +12 more

ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS

Neuro-Oncology(2018)10.1093/neuonc/noy148.027

N/A

0DataRank · unranked

0 citations

Itay Tirosh, Annabelle Anandappa, Jing Sun, Chang‐Jiun Wu, Evisa Gjini +21 more

Anita Giobbie‐Hurder

Indexed papers

Top data-sharing exemplar

Papers